Trial
NCT03741712
A Study of SHR2554 Alone or in Combination With SHR3680 in the Treatment of mCRPC
Phase ITERMINATEDOTHER/UNKNOWNConfidence: LOW
Sponsor
Jiangsu HengRui Medicine Co., Ltd.
Collaborators
—
Condition
Prostate Cancer
Intervention
SHR3680
Why stopped
According to the available data from the trial，the sponsor determined to terminate this study.
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2021-02-05